BOURRIE, BERNARD,CASELLAS, PIERRE,COSNIER-PUCHEU, SYLVIE,JEGHAM, SAMIR,PERREAUT, PIERRE
申请号：
CR20140414
公开号：
CR20140414A
申请日:
2014.09.09
申请国别(地区):
CR
年份:
2015
代理人:
摘要：
The present Invention relates to combinations of N - [2 - (5 - ilamino Silence a benzothiadiazole) - 6 - (2,6-dichlorophenyl) pirido [2,3-d] pyrimidine 7 - yl] - n '- (1,1-dimethylethyl) - urea and cytarabine, and its use in treating AML or CML.La presente invención se refiere a combinaciones de N-[2-(2,1,3-benzotiadiazol-5-ilamino)-6-(2,6-diclorofenil)pirido[2,3-d]pirimidin-7-il]-N'-(1,1-dimetiletil)-urea y citarabina, y a su uso para tratar la LMA o la LMC.
